Literature DB >> 31925886

Regenerative engineered vascularized bone mediated by calcium peroxide.

Leila Daneshmandi1,2,3,4, Cato T Laurencin1,2,3,4,5,6,7.   

Abstract

One of the main challenges hindering the clinical translation of bone tissue engineering scaffolds is the lack of establishment of functional vasculature. Insufficient vascularization and poor oxygen supply limit cell survival within the constructs resulting in poor osseointegration with the host tissue and eventually leading to inadequate bone regeneration. Inspired by cues from developmental biology, we regenerative engineered a composite matrix by incorporating calcium peroxide (CaO2 ) into poly(lactide-co-glycolide) (PLGA) microsphere-based matrices and sought to assess whether the delivery of the byproducts of CaO2 decomposition, namely O2 , Ca2+ , and H2 O2 could enhance the regeneration of vascularized bone tissue. The composite microspheres were successfully fabricated via the oil-in-water emulsion method. The presence and encapsulation of CaO2 was confirmed using scanning electron microscopy, energy dispersive x-ray spectroscopy, thermogravimetric analysis, and X-ray powder diffraction. The microspheres were further heat sintered into three-dimensional porous scaffolds and characterized for their degradation and release of byproducts. The in vitro cytocompatibility of the matrices and their ability to support osteogenic differentiation was confirmed using human adipose-derived stem cells. Lastly, an in vivo study was performed in a mouse critical-sized calvarial defect model to evaluate the capacity of these matrices in supporting vascularized bone regeneration. Results demonstrated that the presence of CaO2 increased cellularization and biological activity throughout the matrices. There was greater migration of host cells to the interior of the matrices and greater survival and persistence of donor cells after 8 weeks, which in synergy with the composite matrices led to enhanced vascularized bone regeneration.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomaterial; bone; in vivo; regenerative engineering; stem cells

Year:  2020        PMID: 31925886     DOI: 10.1002/jbm.a.36879

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

Review 1.  Emergence of the Stem Cell Secretome in Regenerative Engineering.

Authors:  Leila Daneshmandi; Shiv Shah; Tahereh Jafari; Maumita Bhattacharjee; Deandra Momah; Nikoo Saveh-Shemshaki; Kevin W-H Lo; Cato T Laurencin
Journal:  Trends Biotechnol       Date:  2020-07-01       Impact factor: 19.536

Review 2.  Oxygen-Releasing Biomaterials: Current Challenges and Future Applications.

Authors:  Niels G A Willemen; Shabir Hassan; Melvin Gurian; Jinghang Li; Iris E Allijn; Su Ryon Shin; Jeroen Leijten
Journal:  Trends Biotechnol       Date:  2021-02-16       Impact factor: 21.942

3.  Ultra-low binder content 3D printed calcium phosphate graphene scaffolds as resorbable, osteoinductive matrices that support bone formation in vivo.

Authors:  Leila Daneshmandi; Brian D Holt; Anne M Arnold; Cato T Laurencin; Stefanie A Sydlik
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

Review 4.  Platelet-rich plasma-derived extracellular vesicles: A superior alternative in regenerative medicine?

Authors:  Jiuping Wu; Yingxin Piao; Qinyi Liu; Xiaoyu Yang
Journal:  Cell Prolif       Date:  2021-10-05       Impact factor: 6.831

Review 5.  Graphene-Based Biomaterials for Bone Regenerative Engineering: A Comprehensive Review of the Field and Considerations Regarding Biocompatibility and Biodegradation.

Authors:  Leila Daneshmandi; Mohammed Barajaa; Armin Tahmasbi Rad; Stefanie A Sydlik; Cato T Laurencin
Journal:  Adv Healthc Mater       Date:  2020-10-26       Impact factor: 9.933

6.  Robust phenotypic maintenance of limb cells during heterogeneous culture in a physiologically relevant polymeric-based constructed graft system.

Authors:  Mohammed A Barajaa; Lakshmi S Nair; Cato T Laurencin
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.